Treatment Strategy for Borderline Resectable Pancreatic Cancer With Radiographic Artery Involvement-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment Strategy for Borderline Resectable Pancreatic Cancer With Radiographic Artery Involvement

Published:2016-11 Issue:10 Volume:45 Page:1438-1446
ISSN:0885-3177
Container-title:Pancreas
language:en
Short-container-title:

Author:

Hirono Seiko,Kawai Manabu,Okada Ken-ichi,Miyazawa Motoki,Shimizu Atsushi,Kitahata Yuji,Ueno Masaki,Yamaue Hiroki

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference34 articles.

1. Pancreatic carcinoma;Warshaw;N Engl J Med,1992

2. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors;Conlon;Ann Surg,1996

3. NCCN practice guidelines for pancreatic cancer, version 2.;J Natl Compr Canc Netw,2014

4. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS);Bockhorn;Surgery,2014

5. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease;Katz;J Am Coll Surg,2008

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scoring system to predict positive peritoneal cytology in patients with resectable and borderline resectable pancreatic cancer;Journal of Hepato-Biliary-Pancreatic Sciences;2024-05-12

2. Prognostic impact of the distance from the root of splenic artery to tumor in the patients with pancreatic body or tail cancer;Pancreatology;2024-02

3. Radiographic duodenal invasion is associated with poor prognosis and early recurrence in patients with pancreatic ductal adenocarcinoma;European Journal of Surgical Oncology;2023-10

4. Comparison of the upfront surgery and neoadjuvant therapy in resectable and borderline resectable pancreatic cancer: an updated systematic review and meta-analysis;Updates in Surgery;2023-08-28

5. Efficacy and safety of neoadjuvant nab‐paclitaxel plus gemcitabine therapy in patients with borderline resectable pancreatic cancer: A multicenter single‐arm phase II study (NAC‐GA trial);Annals of Gastroenterological Surgery;2023-07-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3